Silymarin: An option to treat non-alcoholic fatty liver disease

World J Gastroenterol. 2017 Dec 21;23(47):8437-8438. doi: 10.3748/wjg.v23.i47.8437.


We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet associated to an antioxidant complex rich in silymarin, to improve in overweight patients anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat accumulation.

Keywords: Antioxidant; Mediterranean diet; Non-alcoholic fatty liver disease; Silymarin.

Publication types

  • Comment

MeSH terms

  • Antioxidants
  • Humans
  • Lipid Metabolism
  • Non-alcoholic Fatty Liver Disease*
  • Overweight
  • Silymarin*


  • Antioxidants
  • Silymarin